Log in to search using one of your social media accounts:

 

Response of High-Grade Gliomas to Checkpoint Inhibitors Response of High-Grade Gliomas to Checkpoint Inhibitors
How should MRI findings be used to assess response of high-grade gliomas to immunotherapy?Cancer Control: Journal of the Moffitt Cancer Center (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - February 13, 2018 Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news

Smart bomb virus shows promise as brain tumor immunotherapy
(University of Texas M. D. Anderson Cancer Center) A common cold virus engineered to attack the most common and deadly of brain tumors allowed 20 percent of patients with recurrent glioblastoma to live for three years or longer, researchers from The University of Texas MD Anderson Cancer Center report on a phase I clinical trial in the Journal of Clinical Oncology. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 12, 2018 Category: Cancer & Oncology Source Type: news

FDA ’ s Shuren says cell phone RF exposure is safe in light of NTP animal study
The FDA today reiterated its view that radiofrequency energy exposure associated with cell phone use is safe in light of a new study from the National Toxicology Program, which indicated a carcinogenic effect in rats. The study, conducted by the National Institute of Health’s National Institute of Environmental Health Sciences, aimed to evaluate the the effects of high exposure radiofrequency at levels “considerably above the current safety limits for cell phones” to learn more about the effects of radiofrequency energy on animal tissue, according to FDA Center for Devices and Radiological Health Director...
Source: Mass Device - February 5, 2018 Category: Medical Devices Authors: Fink Densford Tags: Clinical Trials Food & Drug Administration (FDA) Oncology Center for Devices and Radiological Health (CDRH) Source Type: news

Scientists target glioma cancer stem cells, which could improve patient survival
(Dartmouth-Hitchcock Medical Center) Brain tumors are responsible for 25 percent of cancer-related deaths in children and young adults. Despite initial response to treatment, most aggressive brain tumors eventually recur and are ultimately incurable. Multiple studies suggest that cancer stem cells within these tumors resist therapy and are responsible for tumor recurrences. Researchers at Dartmouth's Norris Cotton Cancer Center have devised a strategy to treat these tumors by identifying a secretion-mediated pathway that's essential for maintaining glioma cancer stem cells. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 5, 2018 Category: International Medicine & Public Health Source Type: news

Cancer from cellphones? New studies say no need to hang up
Scientists say they could not find hard evidence for concern about brain tumors linked to cellphone radiation (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - February 3, 2018 Category: Consumer Health News Source Type: news

Hopkins-born venture aims to use ultrasound technology to treat brain tumors
A pair of entrepreneurs from Johns Hopkins are working to develop technology that can use sound waves to treat brain tumors. Amir Manbachi, associate director of the Center for Bioengineering Innovation and Design at Hopkins, and Nao J. Gamo, a researcher who specializes in neuroscience, have partnered to build on an idea that was born at Hopkins. Their goal is to create a kind of ultrasound technology that can be used to "burn" brain tumors, as an alternative to invasive surgery. They have been… (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - January 31, 2018 Category: Health Management Authors: Morgan Eichensehr Source Type: news

Doctor reveals when you should seek help for your headache
Dr Michael Munger, president of the American Academy of Family Physicians, warned that headaches - considered the worst kind of pain - can be a sign of brain tumours and aneurysms. (Source: the Mail online | Health)
Source: the Mail online | Health - January 30, 2018 Category: Consumer Health News Source Type: news

Insightec, Virginia Tech collab on focused ultrasound brain disorder R & D
Insightec said today it is partnering with the Virginia Tech Carilion Research Institute looking to develop treatments for brain disorders utilizing the company’s Exablate Neuro focused ultrasound device. The treatments will also utilize Siemens (NYSE:SI) magnetic resonance imaging devices, with potential applications in treating cancer, brain tumors, targeted disruptions of the blood-brain barrier for therapeutic delivery and neuromodulation to treat psychiatric disorders. “There is considerable basic research to be done in order to develop safe and efficacious protocols for these treatments and...
Source: Mass Device - January 29, 2018 Category: Medical Devices Authors: Fink Densford Tags: Neurological Research & Development Ultrasound INSIGHTEC Source Type: news

Gerald J. Glasser Brain Tumor Center Now Open at Overlook Medical...
New location improves access and coordination of care for patients with brain tumors.(PRWeb January 29, 2018)Read the full story at http://www.prweb.com/releases/2018/01/prweb15143129.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - January 29, 2018 Category: Pharmaceuticals Source Type: news

Tessa Jowell is right about cancer treatment: Britain must do better | Christina Patterson
Her fearless speech was also a reasonable demand for more shared knowledge, faster diagnosis and wider access to experimental treatmentsOn 24 May last year, Tessa Jowell found she could not speak. Two days later, she was diagnosed with a brain tumour. Two weeks after that, the tumour was cut out. Six months on, she can ’t say she was cured, but she sure as hell could speak this week.“I don’t think I immediately leapt to the inevitability of cancer,” she told Nick Robinson on the Today programme on Wednesday. “To begin with, I thought I would have this tumour, that it would be operated on and t...
Source: Guardian Unlimited Science - January 26, 2018 Category: Science Authors: Christina Patterson Tags: Cancer research UK news Tessa Jowell Politics Medical research Science Health Society Source Type: news

Tessa Jowell calls for global cooperation to help cancer patients
Labour peer given standing ovation for moving speech in House of Lords about her brain cancerTessa Jowell has received a standing ovation in the House of Lords for a moving speech about her brain cancer in which she urged peers to support an international initiative to share resources, research and new treatments.The former Labour culture secretary, who is seriously ill with a high-grade brain tumour, spoke to a packed house about the importance of “a community of love” for people suffering from cancer.Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - January 25, 2018 Category: Science Authors: Patrick Greenfield Tags: Tessa Jowell Cancer Cancer research Health Medical research House of Lords Politics UK news Science Society Source Type: news

This Tiny Implant Can Deliver Medicine to Your Brain With the Push of a Button
(WASHINGTON) — Scientists have created a hair-thin implant that can drip medications deep into the brain by remote control and with pinpoint precision. Tested only in animals so far, if the device pans out it could mark a new approach to treating brain diseases — potentially reducing side effects by targeting only the hard-to-reach circuits that need care. “You could deliver things right to where you want, no matter the disease,” said Robert Langer, a professor at the Massachusetts Institute of Technology whose biomedical engineering team reported the research Wednesday. Stronger and safer treatment...
Source: TIME: Health - January 25, 2018 Category: Consumer Health News Authors: Lauren Neergaard / AP Tags: Uncategorized APH healthytime medicine onetime Source Type: news

This Tiny Implant Can Deliver Medicine to Your Brain With the Push of a Button
(WASHINGTON) — Scientists have created a hair-thin implant that can drip medications deep into the brain by remote control and with pinpoint precision. Tested only in animals so far, if the device pans out it could mark a new approach to treating brain diseases — potentially reducing side effects by targeting only the hard-to-reach circuits that need care. “You could deliver things right to where you want, no matter the disease,” said Robert Langer, a professor at the Massachusetts Institute of Technology whose biomedical engineering team reported the research Wednesday. Stronger and safer treatment...
Source: TIME: Science - January 25, 2018 Category: Science Authors: Lauren Neergaard / AP Tags: Uncategorized APH healthytime medicine onetime Source Type: news

Girl, 3, with brain tumour struggles to feed herself
Edie Molyneux, from Tranmere, will likely die young because of the rare mass on her brain, known as a diffuse intrinsic pontine glioma. (Source: the Mail online | Health)
Source: the Mail online | Health - January 25, 2018 Category: Consumer Health News Source Type: news

'I am not afraid' Tessa Jowell and her selfless fight against brain cancer and NHS policy
RADIO 4 ’s flagship current affairs show the Today programme broadcasts interactions with politicians on a daily basis but yesterday it ran an interview with a difference. The guest was former culture secretary Tessa Jowell and she was on not to parrot a party line but to speak very personally about her l ife and plans since being diagnosed with an aggressive brain tumour last May. (Source: Daily Express - Health)
Source: Daily Express - Health - January 25, 2018 Category: Consumer Health News Source Type: news

Man's deadly brain tumour has pushed his brain sideways
Despite Callum Hardyman, 19, undergoing a nine-hour operation at Nottingham's Queen's Medical Centre to remove 75 per cent of the tumour, doctors are only able to extend his life, not cure his condition. (Source: the Mail online | Health)
Source: the Mail online | Health - January 25, 2018 Category: Consumer Health News Source Type: news

Combination chemotherapy may significantly improve treatment for deadly brain tumor
(Massachusetts General Hospital) A team led by Massachusetts General Hospital investigators has found that adding the chemotherapy drug hydroxyurea to the current chemotherapy protocol for glioblastoma significantly increased survival in animal models. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - January 22, 2018 Category: Cancer & Oncology Source Type: news

DIPG tumor patterns offer new insight on survival
(Michigan Medicine - University of Michigan) A small subset of patients with tumors that bear mutations in a gene in the basic packaging of DNA (known as histone mutations) may have better outcomes than others, suggests new research from Michigan Medicine's Pediatric Brain Tumor Research Initiative. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 17, 2018 Category: International Medicine & Public Health Source Type: news

Pregnant teen given months to live gives birth
Dana Scatton, 17, delivered a healthy baby girl last week after being given three to nine months to live in December. The teen from Pennsylvania was diagnosed with a rare brain tumor. (Source: the Mail online | Health)
Source: the Mail online | Health - January 10, 2018 Category: Consumer Health News Source Type: news

Pregnant teen given months to live with DIPG gives birth
Dana Scatton, 17, delivered a healthy baby girl last week after being given three to nine months to live in December. The teen from Pennsylvania was diagnosed with a rare brain tumor. (Source: the Mail online | Health)
Source: the Mail online | Health - January 10, 2018 Category: Consumer Health News Source Type: news

Dr. Kurt Jaeckle to Lead Phase III Clinical Trial of Novel Drug...
Atlantic Health System's Gerald J. Glasser Brain Tumor Center, one of four sites in the country, opens phase III study of first-in-class drug VAL-083, which has already shown promise in...(PRWeb January 10, 2018)Read the full story at http://www.prweb.com/releases/2018/01/prweb15074260.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - January 10, 2018 Category: Pharmaceuticals Source Type: news

Immune Boosting Virus Could Be Used to Treat Brain Tumors Immune Boosting Virus Could Be Used to Treat Brain Tumors
A trial of a potential new brain cancer treatment has shown that a virus injected directly into the bloodstream can reach tumors deep inside the brain and switch on the body's own defense system to attack them.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - January 4, 2018 Category: Consumer Health News Tags: Medscape Today News Source Type: news

Sickness bug could help fight brain cancer by helping boost the immune system
BRAIN tumours affect around 11,000 people in the UK each year and fewer than one in seven can expect to survive longer than a decade. But new research has found a virus, best known for giving children stomach bugs, could help. (Source: Daily Express - Health)
Source: Daily Express - Health - January 4, 2018 Category: Consumer Health News Source Type: news

Medical News Today: Cancer: Virus fuels immune system to attack brain tumors
From the bloodstream, a wild virus selectively entered cancer cells in patients' brain tumors and made it easier for the immune system to destroy them. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - January 4, 2018 Category: Consumer Health News Tags: Cancer / Oncology Source Type: news

Immune boosting virus could be used to treat brain tumors
LONDON (Reuters) - A trial of a potential new brain cancer treatment has shown that a virus injected directly into the bloodstream can reach tumors deep inside the brain and switch on the body's own defense system to attack them. (Source: Reuters: Health)
Source: Reuters: Health - January 3, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Tailoring cancer treatments to individual patients
(University of Texas at Austin, Texas Advanced Computing Center) The Center for Computational Oncology developed computer models to predict how cancer will progress in a specific individual, based on tissue, cellular and subcellular protein signaling responses. The models can predict how brain tumors (gliomas) will grow with much greater accuracy than previous models. Recently, the group began a clinical study to predict how an individual's cancer will progress after one cycle of therapy, and to use that prediction to plan the course of treatment. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 3, 2018 Category: International Medicine & Public Health Source Type: news

Virus could treat brain tumours by boosting immune system
(University of Leeds) Virus could act as an immunotherapy when injected into bloodstream. First human trial shows virus can cross blood-brain barrier to infect tumors and stimulate the body's immune system to attack the cancer. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - January 3, 2018 Category: Cancer & Oncology Source Type: news

Variation Seen in Hospice Use for Malignant Glioma
Differences by race, sex, age, level of education, urban versus rural residence identified (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - December 28, 2017 Category: Cancer & Oncology Tags: Family Medicine, Geriatrics, Internal Medicine, Neurology, Nursing, Oncology, Anesthesiology & amp; Pain, Journal, Source Type: news

Many with Deadly Brain Cancer Don't Opt for Hospice Care
Source: HealthDay Related MedlinePlus Pages: Brain Tumors, Hospice Care (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - December 28, 2017 Category: Consumer Health News Source Type: news

Many With Deadly Brain Cancer Don't Opt for Hospice Care
THURSDAY, Dec. 28, 2017 -- Many patients with a deadly type of brain tumor don't receive adequate hospice care, a new study finds. Massachusetts General Hospital Cancer Center researchers analyzed data from more than 12,000 patients in the United... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - December 28, 2017 Category: General Medicine Source Type: news

Pet Dogs May Speed Human Brain Cancer Trials
Source: HealthDay Related MedlinePlus Pages: Brain Tumors, Pet Health (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - December 26, 2017 Category: Consumer Health News Source Type: news

Medical News Today: Electric field therapy boosts survival from deadly brain tumor
Glioblastoma is a deadly brain cancer with poor outcomes. But the final results of a phase III trial reveal that a novel treatment could increase survival. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - December 22, 2017 Category: Consumer Health News Tags: Cancer / Oncology Source Type: news

Electric device slows growth of deadly brain tumors
In a recent clinical trial, researchers at Northwestern Medicine successfully slowed the growth of a deadly brain tumor using a new electric device. (Source: Health News - UPI.com)
Source: Health News - UPI.com - December 20, 2017 Category: Consumer Health News Source Type: news

Many brain tumor patients do not receive adequate end-of-life care
(Massachusetts General Hospital) While more than 60 percent of patients with the brain tumors called malignant gliomas enroll in hospice services, almost a quarter of them do so within a week of death, probably too late for patients and family members to benefit from hospice care. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - December 20, 2017 Category: Cancer & Oncology Source Type: news

UCLA grant program funds interdisciplinary brain cancer research
When a neurosurgeon looks at a glioblastoma, an aggressive form of brain cancer, she sees a dark mass bullying its way through the brain. When an oncologist talks to a patient with glioblastoma, he tempers expectations, talking in months rather than years. When a molecular biologist thinks about glioblastoma, she thinks about the tumor ’s sweet tooth — the sugar it consumes to fuel its frenetic growth. And when you put all these people together — you get a plan to fight cancer.Armed with new research tools and a grant from the David Geffen School of Medicine ’s newSeed Grant Program, a team of UCLA ...
Source: UCLA Newsroom: Health Sciences - December 18, 2017 Category: Universities & Medical Training Source Type: news

Study: Use radiosurgery for certain brain lesion patients
In a subset of patients, radiosurgery may be the best choice for those with...Read more on AuntMinnie.comRelated Reading: ASTRO: SRS decreases local brain tumor recurrence ASTRO: SRS better than whole-brain radiotherapy (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - December 18, 2017 Category: Radiology Source Type: news

Novel mechanism that protects from glioblastoma identified
(Centro Nacional de Investigaciones Oncol ó gicas (CNIO)) A group of researchers at the Spanish National Cancer Research Centre (CNIO) have identified a protein called RanBP6 as a new regulator of EGFR. In a paper published in Nature Communications they show how silencing of RanBP6 promoted glioma growth, by upregulating EGFR expression. Moreover, reconstitution of RanBP6 in a mouse xenograft model leads to reduction in tumor growth. Authors state that these findings might have " important clinical implications " . (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - December 18, 2017 Category: Biology Source Type: news

Bringing Robotics into the Cath Lab to Protect Physicians
Percutaneous Coronary Intervention (PCI, or angioplasty with stent) is a common procedure used to treat patients with obstructive coronary artery disease, with an estimated 600,000 procedures performed annually in the United States. PCI has a low risk of complications for patients, but that's not the case for clinicians. Patients receive a dose of radiation during a PCI procedure, which takes anywhere from 30 minutes to a few hours. Interventional cardiologists and cardiac catheterization laboratory personnel are exposed to ionizing radiation all day, every day. Protective measures, such as radiation safety caps,...
Source: MDDI - December 15, 2017 Category: Medical Devices Authors: Heather R. Johnson Tags: Medical Device Business Source Type: news

Insightec raises $150m in Series E
Insightec said yesterday it raised $150 million in a Series E round of financing led by Koch Industries’ Koch Disruptive Technologies to support its MRI-guided focused ultrasound technologies. The round was led by Koch Disruptive Technologies and joined by existing investors Elbit Imaging, York Capital, Focus Holdings, GE Healthcare (NYSE:GE), GEOC and Meditech Advisors, the Israel-based company said. “This investment aligns well with the founding principles of both Koch Disruptive Technologies and Koch Industries. With a track record of driving innovation and improving patient outcomes, Insightec has...
Source: Mass Device - December 15, 2017 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News INSIGHTEC Source Type: news

Trust and charity create brain tumour specialist nurse post
A major London hospital trust has appointed its first clinical nurse specialist to focus on the quality of life for brain tumour patients. (Source: Nursing Times)
Source: Nursing Times - December 13, 2017 Category: Nursing Source Type: news

New weakness found in most common childhood malignant brain tumor
(Queen Mary University of London) A new weakness found in medulloblastoma, the most common form of childhood brain tumor, could lead to more personalized medicine and improved treatment for some patients, according to an early study by Queen Mary University of London. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - December 5, 2017 Category: Cancer & Oncology Source Type: news

Insightec wins FDA nod for Exablate Neuro glioblastoma trial
Insightec said today it won FDA approval to launch a safety and feasibility trial of its Exablate Neuro, testing its ability to disrupt the blood brain barrier in patients with glioblastoma. The Exablate Neuro device, which won FDA approval last July for treating essential tremor, uses high-intensity, focused ultrasound to thermally ablate targeted tissue, guided by continuous magnetic resonance imaging; the procedure can be performed non-invasively through an intact skull. In the trial, a research team will inject commonly used a sonographic microbubble solution into the bloodstream of a patient with a malignant...
Source: Mass Device - November 28, 2017 Category: Medical Devices Authors: Fink Densford Tags: Clinical Trials Food & Drug Administration (FDA) Neurological INSIGHTEC Source Type: news

London girl who had brain tumour now doing cartwheels
Indigo McGregor, from London, deteriorated as the growth pressed against her brain stem and was forced to use a wheelchair. But she made an amazing recovery after live-saving surgery. (Source: the Mail online | Health)
Source: the Mail online | Health - November 28, 2017 Category: Consumer Health News Source Type: news

Girl who had brain tumour now doing cartwheels
Indigo McGregor, from London, deteriorated as the growth pressed against her brain stem and was forced to use a wheelchair. But she made an amazing recovery after live-saving surgery. (Source: the Mail online | Health)
Source: the Mail online | Health - November 28, 2017 Category: Consumer Health News Source Type: news

Cancer drug starts clinical trials in human brain-cancer patients
(University of Illinois at Urbana-Champaign) A drug that spurs cancer cells to self-destruct has been cleared for use in a clinical trial of human patients with anaplastic astrocytoma, a rare malignant brain tumor, and glioblastoma multiforme, an aggressive late-stage cancer of the brain. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - November 27, 2017 Category: Cancer & Oncology Source Type: news

Promising target for treating brain tumors in children
(Ann& Robert H. Lurie Children's Hospital of Chicago) Findings published in Oncotarget offer new hope for children with highly aggressive brain tumors like atypical teratoid/rhabdoid tumor (AT/RT) and medulloblastoma. Previously, the authors of the study have shown that an experimental drug that inhibits polo-like kinase 4 (PLK4) stopped pediatric brain tumor growth in vitro. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 27, 2017 Category: International Medicine & Public Health Source Type: news

Henry Marsh: 'Ukraine is like a Trabant that wants to be a Ferrari'
Henry Marsh is a celebrated neurosurgeon who travels the world teaching his exacting craft. Robert McCrum joins him in Ukraine as he tries to save the life of 11-year-old ViktoriaWe joined the green-gowned brain surgery team soon after daybreak. The chill of the operating theatre was filled with the inevitable frisson of nerves before a big op. Inside the Orlika Street children ’s hospital in the suburbs ofLviv, on the western edge of Ukraine, the patient was waiting for us, under halogen lights, anaesthetised upon the table.She was corpse-like in unconsciousness. Her chilled cerise fingernails offered a poignant rem...
Source: Guardian Unlimited Science - November 26, 2017 Category: Science Authors: Robert McCrum Tags: Neuroscience Ukraine Medicine Education Source Type: news

WATCH: 4-year-old girl receives hundreds of books for Lena's Library while battling brain cancer
Lena Tietjen has received hundreds of packages filled with books for her own reading library while she begins to receive treatment and care for an inoperable malignant brain tumor. (Source: ABC News: Health)
Source: ABC News: Health - November 22, 2017 Category: Consumer Health News Tags: Lifestyle Source Type: news

That Time A Researcher Wished His Brain Tumor Had A Share Button
Why one researcher and data evangelist wishes he could more easily share the data that was collected in during his own brain surgery. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - November 21, 2017 Category: Pharmaceuticals Authors: Matthew Herper, Forbes Staff Source Type: news

Ziopharm says its brain cancer drug helped trial patients live more than a year
A Boston biotech with a unique approach to treating an aggressive brain tumor, Ziopharm Oncology reported this weekend that its combination of experimental drugs has helped 15 patients survive about twice as long as they would have otherwise in an early-stage trial. Ziopharm (Nasdaq: ZIOP) reported the updated trial data in patients with recurrent glioblastoma at the Society for Neuro-Oncology this weekend. The 15 patients are all being treated with Ziopharm’s gene therapy, called Ad-RTS-hIL-12,… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - November 20, 2017 Category: Biotechnology Authors: Don Seiffert Source Type: news